HER2-positive Breast Cancer Registry
NCT06603597 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000
Last updated 2025-09-10
Summary
The goal of this observational study is to better understand links between patient or tumor characteristics and outcomes in HER2-positive breast cancer.
Conditions
- HER2 + Breast Cancer
Sponsors & Collaborators
-
Priyanka Sharma
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-09-27
- Primary Completion
- 2044-10-31
- Completion
- 2044-10-31
Countries
- United States
Study Locations
More Related Trials
-
Analysis of Brain Metastasis in Patients With Breast Cancer, With and Without Over-Expression of HER-2
NCT00071383 ·Status: COMPLETED
-
Discordant HER2/Neu Status of Breast Cancer.
NCT01935739 ·Status: COMPLETED
-
Personalized Detection of ctDNA for Patients With HER2-Positive Metastatic Breast Cancer Patients Who Achieved Durable Response to Anti-HER2 Treatment
NCT06663787 ·Status: ACTIVE_NOT_RECRUITING
-
Tumor Characteristics and Survival Rate of HER2-Low Breast Cancer Patients
NCT05754047 ·Status: COMPLETED
-
Phase II Study of Systemic Screening in Pathologic Node Positive Breast Cancer
NCT06833502 ·Status: RECRUITING ·Phase: PHASE2
-
Comparative Expression of ER,PR and HER2/Neu in Initial and Recurrent Breast Cancer.
NCT07056205 ·Status: ENROLLING_BY_INVITATION
-
Predictive Value of Tumor Vascular Normalization Scoring in HER-2 Positive Breast Cancer
NCT06868758 ·Status: ACTIVE_NOT_RECRUITING
-
A Study on the Epidemiology and Testing of Human Epidermal Growth Factor-Receptor 2 (HER2) in Breast Cancer in Germany
NCT02666261 ·Status: COMPLETED
-
TME Alteration in HER2 Positive Breast Cancer
NCT06533670 ·Status: ACTIVE_NOT_RECRUITING
-
Real-World Data on First-line Treatment of Hormone Receptor-positive, HER2-negative, Metastatic Breast Cancer in Brazil
NCT05034393 ·Status: COMPLETED
-
Breast Cancer Registry for Participants With Breast Cancer or Characteristics of Hereditary Breast Cancer
NCT00666731 ·Status: COMPLETED
-
High Risk Breast Clinic: Protocol for Women at Increased Risk for Developing Breast Cancer
NCT00291096 ·Status: RECRUITING
-
HER2 Expression of CTC to Predict Response in HER2-low Advanced Breast Cancer Patients Treated With ADC
NCT05834699 ·Status: UNKNOWN
-
Establishment of Normal Breast Epithelial Cell Lines From Patients at High Risk for Breast Cancer
NCT00001496 ·Status: COMPLETED
-
Analysis of Circulating Tumor DNA (ctDNA) in HER2-low Advanced/Metastatic Breast Cancer
NCT06706557 ·Status: RECRUITING
-
A Study of Changes in Ki67 Expression in People With Breast Cancer Receiving Endocrine Therapy Before Surgery
NCT06127979 ·Status: RECRUITING ·Phase: NA
-
(Oncotype DX®) in Estrogen Receptor Positive (ER+) HER-2 Negative (HER 2-) 1-3 Node Positive (pN1) Breast Cancer
NCT02627703 ·Status: UNKNOWN
-
A Composite Assay for HER2-positive Early-stage Breast Cancer Management
NCT06762977 ·Status: RECRUITING
-
Τreatment Standards and Outcomes of Patients With ER/PR Positive, HER2-negative Metastatic Breast Cancer
NCT04247035 ·Status: UNKNOWN
-
InheriteD brEast caNcer iTalian regIsTrY A Retrospective-prospective Observational Cohort Study to Evaluate Cancer Prevention Strategies in Women With a Deleterious Mutation in BRCA1-2
NCT05835739 ·Status: RECRUITING
-
Women At Risk: The High Risk Breast Cancer Program
NCT01034891 ·Status: UNKNOWN
-
Biological Characteristics of Older Women (> 70 Years) With ER Positive, HER2 Negative Early Breast Cancer
NCT05734950 ·Status: UNKNOWN
-
Prospective Cohort for Tumor Bed Boost Radiotherapy in HER2 Positive Breast Cancer
NCT05893966 ·Status: RECRUITING
-
Molecular Profiling of Stage II and III Breast Cancer in Latin American Women Receiving Standard-of-Care Treatment
NCT02326857 ·Status: COMPLETED
-
Comprehensive Screening for Women at High Genetic Risk for Developing Breast Cancer
NCT00255060 ·Status: COMPLETED